Viés de alta
ASXC FDA approval sell the leap options
ASXC has FDA approval for the surgical device granted this month.
ASXC has adequate cash for two year burn as sales are ramped up.
Sell the ASXC Jan 2023 leap options and the raw cost is $2 per share. Stock is as of today $3.80 range.
Invest the cash in GGN and trade GGN monthly into the dividend ex-date.
own the stock for nearly free at any cost in 21 months.
good product
small cap with adequate share count and volume.
reasonable speculation
see the links below...
all the best.
ASXC has adequate cash for two year burn as sales are ramped up.
Sell the ASXC Jan 2023 leap options and the raw cost is $2 per share. Stock is as of today $3.80 range.
Invest the cash in GGN and trade GGN monthly into the dividend ex-date.
own the stock for nearly free at any cost in 21 months.
good product
small cap with adequate share count and volume.
reasonable speculation
see the links below...
all the best.
Nota
GGN up today with 2 weeks to monthly distribution dates. Sold mine today...
not an April Fools day joke...
Publicações relacionadas
Aviso legal
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.
Publicações relacionadas
Aviso legal
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.